GVHD Prophylaxis Using PTCY Remains Valid Treatment Option in MDS
Using post-transplant cyclophosphamide (PTCY) for graft-versus-host disease prophylaxis in patients with myelodysplastic syndromes is a valid option compared to antithymocyte ...
Tag: MDS
Low-Dose Revlimid May Delay Time to Blood Transfusion Dependency in MDS
Certain patients with MDS receiving Revlimid demonstrated a manageable safety profile. Patients with non-transfusion dependent myelodysplastic syndromes (MDS) who were ...
Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia
Patients with lower-risk MDS and anemia may benefit from Reblozyl as standard of care. Image generated by Adobe Firefly.Reblozyl (luspatercept) ...
In a World of Rushing, Cancer Taught Me to Slow Down
As a child and now an adult I remember an oft-repeated quote, “The only constant is change.” The older I ...
Why Transfusion Independence Matters for Patients With MDS
Among patients with myelodysplastic syndromes (MDS), treatment with Reblozyl (luspatercept) resulted in at least 12 weeks of blood transfusion independence ...
My Worries About Being Old as an MDS Survivor
I am amazed at people who are warriors of cancer and still worry about being old. I have a friend ...
‘Tempo’ of MDS Helps With Timing for Stem Cell Transplants
During the treatment process for patients with myelodysplastic syndromes (MDS), the time in which patients receive stem cell transplants matters, ...
A True Partner in Cancer Healing
As is obvious, incredible attention to detail must be given to facilitate return to health following stem cell transplant. Keri's ...
The Importance of Self-Image With Cancer
One of the problems in the United States is our infatuation with body image.This obsession with looks was demonstrated by ...
Cancer Survivors and Olympians Need to Be in Tune With Their Bodies
The Olympics fascinate me for many reasons. I watch in awe as the athletes who have trained every single day ...
NCCN Recommends Rytelo for Anemia in Patients With MDS
Rytelo is recommended for patients with lower-risk myelodysplastic syndromes (MDS) who experience anemia. The National Comprehensive Cancer Network (NCCN) now ...
Cyclophosphamide ‘Opens the Registry Up’ for Stem Cell Transplants
Post-transplant cyclophosphamide may help more patients with blood cancer be eligible for stem cell transplants. For patients with blood cancers ...